BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 37628989)

  • 1. Genetic and Epigenetic Features of Uveal Melanoma-An Overview and Clinical Implications.
    Pašalić D; Nikuševa-Martić T; Sekovanić A; Kaštelan S
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of microRNAs and their implications in uveal melanoma.
    Yang C; Wang Y; Hardy P
    Cell Mol Life Sci; 2021 Jan; 78(2):545-559. PubMed ID: 32783068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Epigenetics in Uveal Melanoma.
    Li Y; Jia R; Ge S
    Int J Biol Sci; 2017; 13(4):426-433. PubMed ID: 28529451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic insights into uveal melanoma.
    Sharma A; Stei MM; Fröhlich H; Holz FG; Loeffler KU; Herwig-Carl MC
    Clin Genet; 2018 May; 93(5):952-961. PubMed ID: 28902406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs and Uveal Melanoma: Understanding the Diverse Role of These Small Molecular Regulators.
    Aughton K; Kalirai H; Coupland SE
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.
    Larsen AC; Holst L; Kaczkowski B; Andersen MT; Manfé V; Siersma VD; Kolko M; Kiilgaard JF; Winther O; Prause JU; Gniadecki R; Heegaard S
    Acta Ophthalmol; 2014 Sep; 92(6):541-9. PubMed ID: 24373459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver metastasis in uveal melanoma - treatment options and clinical outcome.
    Kaštelan S; Mrazovac Zimak D; Ivanković M; Marković I; Gverović Antunica A
    Front Biosci (Landmark Ed); 2022 Feb; 27(2):72. PubMed ID: 35227015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting primary and metastatic uveal melanoma with a G protein inhibitor.
    Onken MD; Makepeace CM; Kaltenbronn KM; Choi J; Hernandez-Aya L; Weilbaecher KN; Piggott KD; Rao PK; Yuede CM; Dixon AJ; Osei-Owusu P; Cooper JA; Blumer KJ
    J Biol Chem; 2021; 296():100403. PubMed ID: 33577798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacement and desmoplastic histopathological growth patterns: A pilot study of prediction of outcome in patients with uveal melanoma liver metastases.
    Barnhill R; Vermeulen P; Daelemans S; van Dam PJ; Roman-Roman S; Servois V; Hurbain I; Gardrat S; Raposa G; Nicolas A; Dendale R; Pierron G; Desjardins L; Cassoux N; Piperno-Neumann S; Mariani P; Lugassy C
    J Pathol Clin Res; 2018 Oct; 4(4):227-240. PubMed ID: 29917326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High EIF4E2 expression is an independent prognostic risk factor for poor overall survival and recurrence-free survival in uveal melanoma.
    Yang B; Gu A; Wu Y
    Exp Eye Res; 2021 May; 206():108558. PubMed ID: 33785306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Methylation and Uveal Melanoma.
    Yang ZK; Yang JY; Xu ZZ; Yu WH
    Chin Med J (Engl); 2018 Apr; 131(7):845-851. PubMed ID: 29578129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
    Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
    Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic prognostication in uveal melanoma.
    Dogrusöz M; Jager MJ
    Acta Ophthalmol; 2018 Jun; 96(4):331-347. PubMed ID: 29105334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spliceosome Mutations in Uveal Melanoma.
    Nguyen JQN; Drabarek W; Yavuzyigitoglu S; Medico Salsench E; Verdijk RM; Naus NC; de Klein A; Kiliç E; Brosens E
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EPIGENETIC CHANGES IN MALIGNANT UVEAL MELANOMA AND POSSIBILITIES OF THEIR THERAPEUTIC TARGETING.
    Smolková B; Demková L
    Cesk Slov Oftalmol; 2020; 76(2):55-60. PubMed ID: 33126799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uveal melanoma: A pathologist's perspective and review of translational developments.
    Schoenfield L
    Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential Role of Selected miRNA in Uveal Melanoma Primary Tumors as Early Biomarkers of Disease Progression.
    Wróblewska JP; Lach MS; Ustaszewski A; Kulcenty K; Ibbs M; Jagiełło I; Suchorska WM; Marszałek A
    Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32131485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future perspectives of uveal melanoma blood based biomarkers.
    Beasley AB; Chen FK; Isaacs TW; Gray ES
    Br J Cancer; 2022 Jun; 126(11):1511-1528. PubMed ID: 35190695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characteristics of liver metastases from uveal melanoma.
    Meir T; Dror R; Yu X; Qian J; Simon I; Pe'er J; Chowers I
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4890-6. PubMed ID: 17962435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.